| Quality of life and use of health care among people with genital herpes in France. F Taboulet, B Halioua, JE Malkin Acta dermato-venereologica 79 (5), 1999 | 31 | 1999 |
| The influence of drug use in university hospitals on the pharmaceutical consumption in their surrounding communities A Gallini, R Legal, F Taboulet British Journal of Clinical Pharmacology 75 (4), 1142-1148, 2013 | 28 | 2013 |
| Patient access to orphan drugs in France M Bourdoncle, B Juillard-Condat, F Taboulet Orphanet journal of rare diseases 14, 1-9, 2019 | 24 | 2019 |
| Medical and socio-economical impact of drug-induced adverse reactions E Apretna, F Haramburu, F Taboulet, B Bégaud Presse Medicale (Paris, France: 1983) 34 (4), 271-276, 2005 | 20 | 2005 |
| Drug selection in French university hospitals: analysis of formularies for nine competitive pharmacological classes A Gallini, B Juillard‐Condat, MC Saux, F Taboulet British journal of clinical pharmacology 72 (5), 823-831, 2011 | 19 | 2011 |
| Neurosurgical and endovascular treatment of intracranial aneurysms: a cost analysis of two different strategies at the University Hospital of Bordeaux (France) AC Ballet, J Guerin, J Berge, F Taboulet, S Martin, V Philip, MC Saux, ... Neuro-chirurgie 48 (5), 419-425, 2002 | 18 | 2002 |
| Prescribing drugs by international non-proprietary name: the perception of health and non-health professionals J Biga, F Taboulet, M Lapeyre-Mestre, AM Duguet, S Vincent, ... Therapie 60 (4), 401-407, 2005 | 17 | 2005 |
| Conséquences médicales et socio-économiques des effets indésirables médicamenteux E Apretna, F Haramburu, F Taboulet, B Bégaud La Presse Médicale 34 (4), 271-276, 2005 | 16 | 2005 |
| Impact of etanercept on the costs of rheumatoid arthritis (RA): results from a French observational study B Juillard-Condat, A Constantin, A Cambon-Thomsen, R Bourrel, ... Joint Bone Spine 75 (1), 25-28, 2008 | 15 | 2008 |
| The impact of European embryonic stem cell patent decisions on research strategies A Mahalatchimy, E Rial-Sebbag, AM Duguet, F Taboulet, ... Nature Biotechnology 33 (1), 41-43, 2015 | 14 | 2015 |
| Présentation d'une méthodologie permettant de mesurer en quantité et de comparer les consommations pharmaceutiques F Taboulet Journal d'économie médicale 8 (1), 37-63, 1990 | 14 | 1990 |
| Exclusion of patentability of embryonic stem cells in Europe: another restriction by the European Patent Office A Mahalatchimy, E Rial-Sebbag, M Duguet, A Cambon-Thomsen, ... European Intellectual Property Review 37 (1), 25-28, 2015 | 9 | 2015 |
| Regional variations in quinolone use in France and associated factors A Gallini, F Taboulet, R Bourrel European journal of clinical microbiology & infectious diseases 31, 2911-2918, 2012 | 9 | 2012 |
| Coût de la polyarthrite rhumatoïde en France: comparaison léflunomide/étanercept B Juillard-Condat, A Constantin, A Cambon-Thomsen, R Bourrel, ... Therapie 62 (2), 137-142, 2007 | 7 | 2007 |
| The health care crisis: end or beginning of the heyday of medical decision support systems? T Timpka Methods of Information in Medicine 33 (04), 332-335, 1994 | 6 | 1994 |
| Don d’ovocytes et tourisme procréatif: comment sortir de l’impasse? F Taboulet Médecine & Droit 2014 (125), 40-45, 2014 | 5 | 2014 |
| Le périmètre en mosaïque des médicaments remboursables: pourquoi tant d’exceptions? B Juillard-Condat, F Taboulet Médecine & droit 2010 (103), 122-133, 2010 | 5 | 2010 |
| Traitement neurochirurgical et endovasculaire des anévrismes intracrâniens: Approche économique de deux alternatives thérapeutiques sur le CHU de Bordeaux AC BALLET, J Guérin, J Berge, F Taboulet, S Martin, V Philip Neuro-chirurgie (Paris) 48 (5), 419-425, 2002 | 5 | 2002 |
| Comprendre la pharmacoéconomie A Beresniak, S Cros-Friedmann, F Taboulet John Libbey Eurotext, 1996 | 5 | 1996 |
| La contraception d’urgence délivrée aux mineures: enjeux de sécurité et de santé publique F TABOULET, V SIRANYAN Panorama de droit pharmaceutique–2014. Revue Générale de Droit médical. Les …, 2015 | 4 | 2015 |
